Hiroshi Arai
Hiroshi Arai has a total of 338 co-authors. Here are the top co-authors by number of shared publications:
- Mitsuhiro Kato
Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan
5 shared publications Shintaro Okada
Departments of Pediatrics, Osaka University Medical School, Osaka, Japan
5 shared publicationsToshisaburo Nagai
Section of Pediatrics, Toyonaka Municipal Hospital, Osaka, Japan
5 shared publications- Yukihiro Kitai
Department of Pediatric Neurology, Bobath Memorial Hospital, Osaka, Japan
5 shared publications - Akihisa Okumura
Department of Pediatrics, Aichi Medical University, Japan
4 shared publications - Hirotomo Saitsu
Department of Biochemistry Hamamatsu University School of Medicine Hamamatsu Japan
4 shared publications
Latest Publications
- 7 September 2023
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 47, 41-46
Childhood-onset epilepsy in patients with dyskinetic cerebral palsy caused by basal ganglia and thalamic lesions
- 7 September 2023
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 47, 41-46
Childhood-onset epilepsy in patients with dyskinetic cerebral palsy caused by basal ganglia and thalamic lesions
- Open Access
- 2 March 2023
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 447, 120597
Association between cerebrospinal fluid parameters and developmental and neurological status in glucose transporter 1 deficiency syndrome
- 2 March 2023
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 447, 120597
Open AccessAssociation between cerebrospinal fluid parameters and developmental and neurological status in glucose transporter 1 deficiency syndrome
- 1 March 2022
- Published by Institute of Electrical Engineers of Japan (IEE Japan) in IEEJ Transactions on Fundamentals and Materials
- Vol. 142 (3) , 80-85
Measurement of Ionization Coefficients in He/H2O (95.4ppm) Mixture
Measurements of the first and second ionization coefficients α and γT in He/H2O (95.4 ppm) mixture are carried out using a steady state Townsend method. Observed ionized multiplication currents are analyzed by Nakamura's plot to determine both of the ionization coefficients. The obtained first ionization coefficient in the mixture is large compared with those of helium and water molecule in the range of the reduced electric field E/N≦1131 Td (E/p0≦400 V/cm Torr) affected by Penning ionization between the metastable excited He atoms and H2O molecules. Therefore, it is validated that the Penning ionization is formed in the mixture and the related behaviors of the metastable excited He atoms He(23S1) and He(21S0) are also discussed in this paper.
- 1 March 2022
- Published by Institute of Electrical Engineers of Japan (IEE Japan) in IEEJ Transactions on Fundamentals and Materials
- Vol. 142 (3) , 80-85
Measurement of Ionization Coefficients in He/H2O (95.4ppm) Mixture
Measurements of the first and second ionization coefficients α and γT in He/H2O (95.4 ppm) mixture are carried out using a steady state Townsend method. Observed ionized multiplication currents are analyzed by Nakamura's plot to determine both of the ionization coefficients. The obtained first ionization coefficient in the mixture is large compared with those of helium and water molecule in the range of the reduced electric field E/N≦1131 Td (E/p0≦400 V/cm Torr) affected by Penning ionization between the metastable excited He atoms and H2O molecules. Therefore, it is validated that the Penning ionization is formed in the mixture and the related behaviors of the metastable excited He atoms He(23S1) and He(21S0) are also discussed in this paper.
- Open Access
- 1 September 2021
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 62 (5) , 567-568
Magnetic resonance imaging abnormalities during the neonatal period in preterm infants with bilirubin encephalopathy
- 1 September 2021
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 62 (5) , 567-568
Open AccessMagnetic resonance imaging abnormalities during the neonatal period in preterm infants with bilirubin encephalopathy
- 1 August 2021
- Published by Elsevier in Pediatric Neurology
- Vol. 121, 56-58
Magnetic Resonance Imaging Findings in Preterm Infants With Bilirubin Encephalopathy Beyond Three Years Corrected Age
- 1 August 2021
- Published by Elsevier in Pediatric Neurology
- Vol. 121, 56-58
Magnetic Resonance Imaging Findings in Preterm Infants With Bilirubin Encephalopathy Beyond Three Years Corrected Age
- 19 March 2021
- Published by S. Karger AG in Neonatology
- Vol. 118 (3) , 301-309
Neonatal Jaundice in Preterm Infants with Bilirubin Encephalopathy
Introduction: The aim of this study is to clarify bilirubin parameters and its treatment in preterm infants with bilirubin encephalopathy (pBE). Methods: We asked the responders to an earlier nationwide Japanese survey on pBE to provide additional information. pBE was diagnosed based on the criteria used in the nationwide survey. We collected data on serum total bilirubin (TB), direct bilirubin (DB), albumin, and unbound bilirubin (UB) levels during the first 8 weeks of life, and on phototherapy and exchange transfusion treatments. Results: We obtained clinical data from 75 patients with pBE from 58 hospitals (response rate of 59%), who were born between 2002 and 2016. The average peak TB level was 12.6 mg/dL (215 μmol/L), and the average age at peak attainment was 19.7 days after birth. Albumin level was Conclusions: Most patients with pBE lacked marked elevations in serum TB levels and the B/A ratio, the peaks of which were sometimes delayed to >4 weeks after birth.
- 19 March 2021
- Published by S. Karger AG in Neonatology
- Vol. 118 (3) , 301-309
Neonatal Jaundice in Preterm Infants with Bilirubin Encephalopathy
Introduction: The aim of this study is to clarify bilirubin parameters and its treatment in preterm infants with bilirubin encephalopathy (pBE). Methods: We asked the responders to an earlier nationwide Japanese survey on pBE to provide additional information. pBE was diagnosed based on the criteria used in the nationwide survey. We collected data on serum total bilirubin (TB), direct bilirubin (DB), albumin, and unbound bilirubin (UB) levels during the first 8 weeks of life, and on phototherapy and exchange transfusion treatments. Results: We obtained clinical data from 75 patients with pBE from 58 hospitals (response rate of 59%), who were born between 2002 and 2016. The average peak TB level was 12.6 mg/dL (215 μmol/L), and the average age at peak attainment was 19.7 days after birth. Albumin level was Conclusions: Most patients with pBE lacked marked elevations in serum TB levels and the B/A ratio, the peaks of which were sometimes delayed to >4 weeks after birth.
- 1 March 2021
- Published by Elsevier in Early Human Development
- Vol. 154, 105319
Auditory brainstem response in preterm infants with bilirubin encephalopathy
- 1 March 2021
- Published by Elsevier in Early Human Development
- Vol. 154, 105319
Auditory brainstem response in preterm infants with bilirubin encephalopathy
- 4 October 2019
- Published by S. Karger AG in Neonatology
- Vol. 117 (1) , 73-79
Diagnosis of Bilirubin Encephalopathy in Preterm Infants with Dyskinetic Cerebral Palsy
Introduction: Very preterm infants are susceptible to bilirubin neurotoxicity, the signs of which are unclear during early infancy. We investigated children born preterm and later diagnosed with bilirubin encephalopathy (BE) to gain insights into accurate early diagnosis. Methods: We identified 93 children born preterm and clinically diagnosed with BE who visited our hospital between 2006 and 2018. Perinatal history, findings of auditory brainstem response (ABR), brain magnetic resonance imaging (MRI), and functional outcomes were investigated retrospectively based on chart review. Results: The mean gestational age and birth weights were 27.2 weeks and 991 g, respectively. During the neonatal period, only 3% (2/71) had exchange transfusions, and none were diagnosed with acute BE. ABR was abnormal in 64% (51/80), but the majority (34/51) required no hearing aids. Brain MRI taken between 6 and 18 months of age revealed bilateral T2 hyperintensity of the globi pallidi in 91% (60/66); subsequently, the rate decreased with age. Functional communication outcomes were markedly superior to gross motor and hand function outcomes. Conclusion: For early diagnosis of BE, brain MRI is recommended at a corrected age of between 6 and 18 months, especially for those with abnormal ABR during early infancy, and even with no apparent history of marked neonatal hyperbilirubinemia.
- 4 October 2019
- Published by S. Karger AG in Neonatology
- Vol. 117 (1) , 73-79
Diagnosis of Bilirubin Encephalopathy in Preterm Infants with Dyskinetic Cerebral Palsy
Introduction: Very preterm infants are susceptible to bilirubin neurotoxicity, the signs of which are unclear during early infancy. We investigated children born preterm and later diagnosed with bilirubin encephalopathy (BE) to gain insights into accurate early diagnosis. Methods: We identified 93 children born preterm and clinically diagnosed with BE who visited our hospital between 2006 and 2018. Perinatal history, findings of auditory brainstem response (ABR), brain magnetic resonance imaging (MRI), and functional outcomes were investigated retrospectively based on chart review. Results: The mean gestational age and birth weights were 27.2 weeks and 991 g, respectively. During the neonatal period, only 3% (2/71) had exchange transfusions, and none were diagnosed with acute BE. ABR was abnormal in 64% (51/80), but the majority (34/51) required no hearing aids. Brain MRI taken between 6 and 18 months of age revealed bilateral T2 hyperintensity of the globi pallidi in 91% (60/66); subsequently, the rate decreased with age. Functional communication outcomes were markedly superior to gross motor and hand function outcomes. Conclusion: For early diagnosis of BE, brain MRI is recommended at a corrected age of between 6 and 18 months, especially for those with abnormal ABR during early infancy, and even with no apparent history of marked neonatal hyperbilirubinemia.
- Open Access
- 1 January 2016
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 56 (5) , 257-263
Percutaneous Glycerol Rhizotomy for Trigeminal Neuralgia Using a Single-Plane, Flat Panel Detector Angiography System: Technical Note
Percutaneous treatments for trigeminal neuralgia (TN) including glycerol rhizotomy (GR), radiofrequency thermocoagulation (RT), and balloon compression (BC) are effective for patients with medical comorbidities and risk factors of microvascular decompression (MVD). These procedures are usually performed under fluoroscopy. Surgeons advance the needle to the trigeminal plexus through the foramen ovale while observing landmarks of fluoroscopic images; however, it is sometimes difficult to appropriately place the needle tip in Meckel's cave. We present the technical details of percutaneous GR using a single-plane, flat panel detector angiography system to check the needle positioning. When the needle tip may be located near the trigeminal cistern, three-dimensional (3-D) bone images are taken with cone-beam computed tomography (CT). These images clearly show the position of the needle tip in Meckel's cave. If it is difficult to place it through the foramen ovale, surgeons perform cone beam CT to observe the actual position of the needle tip at the skull base. After confirming the positional relation between the needle tip and foramen ovale, surgeons can advance it in the precise direction. In 10 procedures, we could place the nerve-block needle in about 14.5 minutes on average without complications. We think that our method is simple and convenient for percutaneous treatments for TN, and it may be helpful for surgeons to perform such treatments.
- 1 January 2016
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 56 (5) , 257-263
Open AccessPercutaneous Glycerol Rhizotomy for Trigeminal Neuralgia Using a Single-Plane, Flat Panel Detector Angiography System: Technical Note
Percutaneous treatments for trigeminal neuralgia (TN) including glycerol rhizotomy (GR), radiofrequency thermocoagulation (RT), and balloon compression (BC) are effective for patients with medical comorbidities and risk factors of microvascular decompression (MVD). These procedures are usually performed under fluoroscopy. Surgeons advance the needle to the trigeminal plexus through the foramen ovale while observing landmarks of fluoroscopic images; however, it is sometimes difficult to appropriately place the needle tip in Meckel's cave. We present the technical details of percutaneous GR using a single-plane, flat panel detector angiography system to check the needle positioning. When the needle tip may be located near the trigeminal cistern, three-dimensional (3-D) bone images are taken with cone-beam computed tomography (CT). These images clearly show the position of the needle tip in Meckel's cave. If it is difficult to place it through the foramen ovale, surgeons perform cone beam CT to observe the actual position of the needle tip at the skull base. After confirming the positional relation between the needle tip and foramen ovale, surgeons can advance it in the precise direction. In 10 procedures, we could place the nerve-block needle in about 14.5 minutes on average without complications. We think that our method is simple and convenient for percutaneous treatments for TN, and it may be helpful for surgeons to perform such treatments.
- Open Access
- 10 April 2015
- Published by The Endocrine Society in Endocrinology
- Vol. 156 (7) , 2518-2529
Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide
Recent studies have revealed that C-type natriuretic peptide (CNP) is a potent stimulator of endochondral bone growth. Nevertheless, the effect of CNP on bone turnover has not yet been well studied. To elucidate this issue, we investigated the bone phenotype of a mouse model with elevated plasma CNP concentrations (SAP-CNP-Tg mice) in the present study. Microcomputed tomography (CT) analysis revealed less bone in femurs, but not in lumber vertebrae, of young adult SAP-CNP-Tg mice than that of wild-type mice. Bone histomorphometry of the tibiae from 8-week-old SAP-CNP-Tg mice showed enhanced osteoblastic and osteoclastic activities, in accordance with elevated serum levels of osteocalcin and tartrate-resistant acid phosphatase-5b, respectively. Next we performed an open and stabilized femoral fracture using 8-week-old SAP-CNP-Tg mice and compared the healing process with age-matched wild-type mice. An immunohistochemical study revealed that CNP and its receptors, natriuretic peptide receptor-B and natriuretic peptide clearance receptor, are expressed in hard calluses of wild-type mice, suggesting a possible role of CNP/natriuretic peptide receptor-B signaling in fracture repair, especially in bone remodeling stage. On micro-CT analysis, a rapid decrease in callus volume was observed in SAP-CNP-Tg mice, followed by a generation of significantly higher new bone volume with a tendency of increased bone strength. In addition, a micro-CT analysis also showed that bone remodeling was accelerated in SAP-CNP-Tg mice, which was also evident from increased serum osteocalcin and tartrate-resistant acid phosphatase-5b levels in SAP-CNP-Tg mice at the remodeling stage of fracture repair. These results indicate that CNP activates bone turnover and remodeling in vivo and possibly accelerates fracture healing in our mouse model.
- 10 April 2015
- Published by The Endocrine Society in Endocrinology
- Vol. 156 (7) , 2518-2529
Open AccessIncreased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide
Recent studies have revealed that C-type natriuretic peptide (CNP) is a potent stimulator of endochondral bone growth. Nevertheless, the effect of CNP on bone turnover has not yet been well studied. To elucidate this issue, we investigated the bone phenotype of a mouse model with elevated plasma CNP concentrations (SAP-CNP-Tg mice) in the present study. Microcomputed tomography (CT) analysis revealed less bone in femurs, but not in lumber vertebrae, of young adult SAP-CNP-Tg mice than that of wild-type mice. Bone histomorphometry of the tibiae from 8-week-old SAP-CNP-Tg mice showed enhanced osteoblastic and osteoclastic activities, in accordance with elevated serum levels of osteocalcin and tartrate-resistant acid phosphatase-5b, respectively. Next we performed an open and stabilized femoral fracture using 8-week-old SAP-CNP-Tg mice and compared the healing process with age-matched wild-type mice. An immunohistochemical study revealed that CNP and its receptors, natriuretic peptide receptor-B and natriuretic peptide clearance receptor, are expressed in hard calluses of wild-type mice, suggesting a possible role of CNP/natriuretic peptide receptor-B signaling in fracture repair, especially in bone remodeling stage. On micro-CT analysis, a rapid decrease in callus volume was observed in SAP-CNP-Tg mice, followed by a generation of significantly higher new bone volume with a tendency of increased bone strength. In addition, a micro-CT analysis also showed that bone remodeling was accelerated in SAP-CNP-Tg mice, which was also evident from increased serum osteocalcin and tartrate-resistant acid phosphatase-5b levels in SAP-CNP-Tg mice at the remodeling stage of fracture repair. These results indicate that CNP activates bone turnover and remodeling in vivo and possibly accelerates fracture healing in our mouse model.